Business
Proposed Placing of new Ordinary Shares
Proposed Placing of new Ordinary Shares.
About this update from Oxford Biomedica Plc
[{"type":"text","content":"\n \n \n RNS Number : 4304Q\n Oxford Biomedica PLC\n 18 June 2020\n \n \n \n \n THIS ANNOUNCEMENT, INCLUDING THE APPENDICES AND THE INFORMATION CONTAINED IN THEM, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.\n \n \n FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN OXFORD BIOMEDICA PLC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH, ANY INVESTMENT DECISION IN RESPECT OF OXFORD BIOMEDICA PLC.\n \n \n THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 596/2014 (\"MAR\").\n \n \n \n LEI: \n \n 213800S1GVQNXQ15K851\n \n \n \n \n \n For immediate release\n \n \n 18 June 2020\n \n \n Oxford Biomedica plc\n \n \n (\"Oxford Biomedica\" or the \"Company\" or the \"Group\")\n \n \n Proposed Placing of new Ordinary Shares\n \n \n \n \n \n Oxford Biomedica, a leading gene and cell therapy group, today announces its intention to conduct a non-pre-emptive placing of up to \n 5.000.000 new ordinary shares of nominal value of 50 pence each in the capital of the company (the \"Placing Shares\") representing approximately 6.5% of the Company's existing issued share capital (the \"Placing\"). The Placing is proposed to raise up to £40 million, before expenses.\n \n \n The Placing will be conducted through a fixed price bookbuilding process (the \"Bookbuild\"), which will be launched immediately following this announcement and is subject to the terms and conditions set out in Appendix 1 to this announcement (such announcement and its appendices together being the \"Announcement\").\n \n The price per Placing Share is 800 pence. \n \n \n Peel Hunt LLP (\"Peel Hunt\") and WG Partners LLP (\"WG\") are acting as joint bookrunners in connection with the Placing.\n \n \n Company overview and recent developments\n \n \n The Company ...